Cargando…

miR-454 promotes survival and induces oxaliplatin resistance in gastric carcinoma cells by targeting CYLD

MicroRNA-454 (miR-454), is involved in the progression of various types of cancers. The present study aimed to evaluate the effect of miR-454 on the progression of gastric cancer. SGC-7901 cells overexpressing or silencing miR454 were constructed via transfection and the survival rate of the cells w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chaoqun, Liu, Jiuyang, Pan, Xuekai, Peng, Chunwei, Xiong, Bin, Feng, Maohui, Yang, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185177/ https://www.ncbi.nlm.nih.gov/pubmed/32346424 http://dx.doi.org/10.3892/etm.2020.8655

Ejemplares similares

MiR-454-3p Promotes Oxaliplatin Resistance by Targeting PTEN in Colorectal Cancer
por: Qian, Xiao-Lan, et al.
Publicado: (2021)

Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin
por: Jiang, Jingting, et al.
Publicado: (2011)

Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway
por: Liu, Jiuyang, et al.
Publicado: (2018)

miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma
por: Qiu, Haijiang, et al.
Publicado: (2016)

miR-135a promotes gastric cancer progression and resistance to oxaliplatin
por: Yan, Lin-Hai, et al.
Publicado: (2016)

miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma
por: Yu, Lei, et al.
Publicado: (2015)

Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5
por: Xu, Guangru, et al.
Publicado: (2018)

High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Yanqing, et al.
Publicado: (2019)

miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6
por: An, Yunhe, et al.
Publicado: (2020)

miR-454-3p promotes of human glioma cell growth by targeting EGR3
por: Shen, Guoliang, et al.
Publicado: (2019)

LncRNA GMDS‐AS1 inhibits lung adenocarcinoma development by regulating miR‐96‐5p/CYLD signaling
por: Zhao, Ming, et al.
Publicado: (2019)

LINC00641/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma
por: Hu, Yunfeng, et al.
Publicado: (2020)

Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR‐195‐5p and ABCG2 pathway
por: Luo, Yaomin, et al.
Publicado: (2023)

Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
por: Wang, De-Ying, et al.
Publicado: (2020)

MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2
por: Wang, Suogang, et al.
Publicado: (2018)

miR-454-3p prevents ox-LDL-induced apoptosis in HAECs by targeting TRPC3
por: Liao, Luming, et al.
Publicado: (2021)

LINC00839 knockdown restrains the metastatic behavior of nasopharyngeal carcinoma by sponging miR-454-3p
por: Zhang, Feng Ying, et al.
Publicado: (2021)

MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis
por: Ren, Liangliang, et al.
Publicado: (2019)

Long non-coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR-454/USP47 axis
por: Yuan, Feng, et al.
Publicado: (2021)

CYLD in health and disease
por: Marín-Rubio, José L., et al.
Publicado: (2023)

The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development
por: Huang, Chaoqun, et al.
Publicado: (2021)

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
por: Elliott, Paul R., et al.
Publicado: (2016)

Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells
por: Wu, Xin, et al.
Publicado: (2014)

MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia
por: Ye, Huashan, et al.
Publicado: (2012)

lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p
por: Long, Jianwen, et al.
Publicado: (2018)

miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer
por: Xie, Xu-Qin, et al.
Publicado: (2020)

Polymorphism in miR-146a associated with clinical characteristics and outcomes in gastric cancer patients treated with adjuvant oxaliplatin and fluoropyrimidines
por: Liao, Yu-Qian, et al.
Publicado: (2015)

lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p
por: Zhang, Zhenming, et al.
Publicado: (2020)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
por: Kupka, Sebastian, et al.
Publicado: (2016)

Predictive Value of MiR-219-1, MiR-938, MiR-34b/c, and MiR-218 Polymorphisms for Gastric Cancer Susceptibility and Prognosis
por: Wu, Yanhua, et al.
Publicado: (2017)

Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2
por: Chen, Lu, et al.
Publicado: (2019)

Long Chain Non-Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3/Cyclin D1
por: Jiang, Datong, et al.
Publicado: (2019)

LncRNA MEG8 promotes TNF-α expression by sponging miR-454-3p in bone-invasive pituitary adenomas
por: Zhu, Hai-Bo, et al.
Publicado: (2021)

Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway
por: Xu, Dan-dan, et al.
Publicado: (2016)

Downregulation of miR-181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF-κB signaling pathway
por: Yang, Xifeng, et al.
Publicado: (2020)

Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer
por: Fang, Ziling, et al.
Publicado: (2017)

Plasma microRNAs, miR-223, miR-21 and miR-218, as Novel Potential Biomarkers for Gastric Cancer Detection
por: Li, Bo-sheng, et al.
Publicado: (2012)

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

Retracted: Long Chain Non-Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3/Cyclin D1
por: Jiang, Datong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g6nh51s7chhvgue4uo8cvl1sir